Navigation Links
First Coast Oncology to Offer Next Generation Proton Therapy
Date:9/17/2008

First Coast Oncology to be the first private practice in the Southeast to

offer state-of-the-art proton radiation therapy

JACKSONVILLE, Fla., Sept. 17 /PRNewswire/ -- Scot Ackerman, M.D., Medical Director, First Coast Oncology, Jacksonville, FL is pleased to announce the recent agreement for the placement of the Monarch250(TM) Proton Therapy System from Still River Systems, Inc, in Jacksonville, Florida.

First Coast Oncology will become the first private practice in the Southeast to add this state-of-the-art treatment modality to its comprehensive cancer center. The Monarch250, a unique compact system, will provide the same precise, non-invasive treatment advantages and capabilities as larger commercially available systems but at a reduced cost. Still River Systems and the Massachusetts Institute of Technology have used advanced superconducting technology to develop the Monarch250 and make proton therapy treatments more practical for freestanding cancer centers and hospitals alike.

"We are excited to have the opportunity to develop with First Coast Oncology, the ability to enhance and expand their cancer treatment capabilities," said Marc Buntaine, CEO of Still River Systems. "The Monarch250 will answer the strong demand from the patient and clinical community for a precise, versatile and affordable proton therapy device."(1)

Proton therapy can deliver with high precision, a burst of radiation to malignant tissue while sparing the adjacent normal tissue, which can result in fewer side effects. Due to the high demand for proton therapy, larger proton centers are operating at capacity and are unable to meet the demand for treatment. First Coast Oncology's new proton therapy acquisition will not only provide patients in Jacksonville with additional access to highly beneficial proton therapy treatment, but also provide treatment to patients in Georgia, Alabama, South Carolina and North Carolina.

"First Coast Oncolog
'/>"/>

SOURCE Still River Systems
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MIGENIX Reports First Quarter Fiscal 2009 Financial Results
2. First 3-D processor runs at 1.4 Ghz on new architecture
3. Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors
4. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
5. A Better Tomorrow Treatment Center Inc., Forterus Inc.s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior
6. Abeome Forms First Class Scientific Advisory Board
7. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
8. National Ovarian Cancer Coalition and PureOlogy to Host First Annual NOCC and PureOlogys Walk to Break the Silence on Ovarian Cancer
9. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
10. Therapure Biopharma Inc. opens for business with first client contracts
11. Peregrine Pharmaceuticals to Report First Quarter FY 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" ... company that develops and commercializes proprietary technologies and products ... operational results for the second fiscal quarter ended March ... Company continued to advance business with our existing customers ... , President and CEO of SQI. "The delivery of ...
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... 21, 2015 Tunnell Consulting, ... firm as senior statistician and Principal, a position to ... in the management and analysis of complex and large ... industries. , “We’re delighted to have Julia join the ... analytics,” said Dr. Philippe Cini, Group Vice President and ...
Breaking Biology Technology:SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2
... - In the first two years of the Governor's ... young company on the cutting edge of its respective industry. This ... that continues the trend begun by start ups like Mithridion, Inc., ... tied for first in 2004. , ,As is the custom, the ...
... aimed at galvanizing the high-tech industry in Wisconsin ... ,Several emerging technology companies have earned much-needed start-up ... submitting winning business plans to a competition that ... Business Plan Contest, produced by the Wisconsin ...
... Kauten is taking direct aim at three unfavorable metrics, and ... , ,Kauten, CEO of QBI Life Sciences , recently ... Polymeric Micelles, a core product. The screening, which employed UGT1A1, ... is used to determine whether a drug will become active ...
Cached Biology Technology:Business plan finalists offer peek into entrepreneurial future 2Business plan finalists offer peek into entrepreneurial future 3Business plan finalists offer peek into entrepreneurial future 4Winners of past business plan contests secure funding, credibility 2Winners of past business plan contests secure funding, credibility 3Winners of past business plan contests secure funding, credibility 4QBI's PreserveX product passes initial test 2QBI's PreserveX product passes initial test 3
(Date:4/13/2015)... a leading cloud-based consumer engagement platform that provides trusted ... communities around health and wellness, announced today the launching ... The ... vehicle to receive validated health information from consumers. ... will allow higi,s trusted partners, on a user opt-in ...
(Date:4/9/2015)... Calif. , April 9, 2015 Synaptics ... interface solutions, announced today that it will report financial ... Thursday, April 23, 2015, after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
(Date:4/6/2015)... Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA ... NXT-ID introduces a new revolutionary method ... surrounds the use of miniature antenna modules for ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... CHAMPAIGN, Ill. The western corn rootworm beetle, a ... costs growers more than $1 billion annually in the U.S., ... giganteus , a potential biofuels crop that would likely be ... survive to adulthood on Miscanthus rhizomes, and adult ...
... Inc., an affiliated corporation of Virginia Tech, announced at ... the source code of GenoCAD to the International Society ... open source development of GenoCAD by the synthetic biology ... to develop a web site allowing users to design ...
... , This release is available in French . ... of the Department of Biological Sciences of Universit du Qubec ... major discovery in the field of molecular biology. They have unlocked ... which is very different from other proteins of the same type ...
Cached Biology News:Miscanthus, a biofuels crop, can host western corn rootworm 2Miscanthus, a biofuels crop, can host western corn rootworm 3Virginia Tech licenses GenoCAD source code to ISCB 2A global breakthrough in the study of a protein linked to the spread of viruses 2
synphilin-1 (V-19)...
... This DuoSet ELISA Development kit contains ... of sandwich ELISAs to measure natural and ... in cell culture supernates and serum.1 Each ... on approximately fifteen 96-well plates, provided that ...
... are designed for use with the ProQuest ... MaV203 contains deletions in the endogenous GAL4 ... two-hybrid systems. The strain also has leu2 ... bait and prey vectors. MaV203 contains three ...
Anti-Cullin-1 Host: rabbit polyclonal Species Reactivity: human, mouse Applications: IHC(P), WB, IP Storage: 4C...
Biology Products: